跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-HYDRALAZINE TABLET 50 MG - HSA Drug Approval Details
Approvals
/
HSA
/
APO-HYDRALAZINE TABLET 50 MG
Approved
THERAPEUTIC
APO-HYDRALAZINE TABLET 50 MG
APOTEX INC (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
May 13, 1988
Approval ID
cbb993bb85904de2
Company
APOTEX INC (CANADA)
Type
Therapeutic
Approval Details
Approval Id
cbb993bb85904de2
Drug Name
APO-HYDRALAZINE TABLET 50 MG
Product Name
APO-HYDRALAZINE TABLET 50 MG
Approval Number
SIN01148P
Approval Date
1988-05-13
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
C02DB02
Atc Item Name
hydralazine
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
HYDRALAZINE HCl
50 mg
HYDRALAZINE HCl
50 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 13, 1988
Approval ID
cbb993bb85904de2
Type
Therapeutic
Back to HSA Approvals